Home > Specialists > Integrative Oncology > Dr. Yehua Shen (沈晔华)
Specialty & Clinical Focus:
Integrative oncology specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on integrative Chinese and Western medicine, minimally invasive tumor ablation, and interventional therapies for pancreatic cancer, primary and metastatic liver cancer, gallbladder cancer, cholangiocarcinoma, and gastrointestinal tumors.
Professional Title & Qualifications:
Chief Physician
Professor
Master's Supervisor
MD
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Integrative Oncology / Minimally Invasive Therapy Center
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Yehua Shen (沈晔华) - Integrative Oncology Specialist
Personal Biography
Dr. Yehua Shen is a Chief Physician, Professor, Master's Supervisor, and MD at the Minimally Invasive Therapy Center and Department of Integrative Oncology, Fudan University Shanghai Cancer Center. Her clinical work focuses on integrative Chinese and Western medicine and minimally invasive interventional treatment for pancreatic cancer, primary and metastatic liver cancer, gallbladder cancer, cholangiocarcinoma, gastrointestinal tumors, and related abdominal and pelvic malignancies.
Her procedural expertise includes microwave, cryoablation and radiofrequency ablation, arterial infusion chemotherapy and embolization, and High-Intensity Focused Ultrasound (HIFU). Dr. Shen trained at Fudan University Shanghai Medical College under Professor Liu Luming and was a visiting scholar at M.D. Anderson Cancer Center in the United States. She also serves as Vice Chairman of the Tumor Ablation Treatment Committee of the Shanghai Anti-Cancer Association. Her annual surgical case volume is reported at approximately 800 cases, and she has published over 40 papers as first or corresponding author while participating in national and international cancer research projects.
Why Consider Dr. Yehua Shen for Your Oncology Care?
Dr. Yehua Shen combines senior clinical experience at Fudan University Shanghai Cancer Center with focused expertise in integrative oncology, minimally invasive tumor ablation, and interventional therapy. Her background includes a visiting scholarship at M.D. Anderson Cancer Center and an annual surgical case volume reported at approximately 800 cases. For international patients considering a remote specialist review before traveling to Shanghai, her experience is particularly relevant to complex liver, pancreatic, gallbladder, cholangiocarcinoma, gastrointestinal, and metastatic liver cancer cases. Preparing imaging, pathology, prior treatment records, and a focused question list in advance can help make the specialist review more structured and useful for planning the next step.
Pre-Travel Case Review & Specialist Liaison
Before traveling to Shanghai for cancer care, a remote specialist review can help clarify key questions before an in-person pathway is planned. MedBridgeNZ coordinates medical-record preparation, translation coordination, client-authorized document transfer, and communication with Dr. Shen’s specialist team at Fudan University Shanghai Cancer Center.
Dr. Shen reviews the submitted records and provides an independent specialist opinion and recommendations, including responses to the questions submitted for review. If an in-person visit is then pursued, MedBridgeNZ can coordinate appointment requests and related travel logistics in Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Yehua Shen
Areas of Expertise
Diagnosis and treatment of liver cancer, pancreatic cancer, colorectal cancer, gastric cancer, metastatic liver cancer, gallbladder cancer, cholangiocarcinoma, etc.
Minimally invasive tumor ablation therapy, including microwave, cryoablation, and radiofrequency ablation (RFA) for primary or metastatic liver cancer and chest/abdominal wall tumors.
Arterial infusion chemotherapy and embolization (interventional therapy) for primary or metastatic liver cancer, pancreatic cancer, and abdominal/pelvic metastatic cancer.
High-Intensity Focused Ultrasound (HIFU/Haifu Knife) treatment for liver cancer, pancreatic cancer, abdominal/pelvic malignancies, and malignant tumors of the chest and abdominal walls.
Drug ablation and other minimally invasive techniques.
Clinical trials of new drugs for liver cancer and pancreatic cancer.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
4.9/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
8,700 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
July 2006 – Present: Chief Physician, Minimally Invasive Therapy Center / Department of Integrative Oncology, Fudan University Shanghai Cancer Center.
May 2012 – November 2012: Visiting Scholar, M.D. Anderson Cancer Center, USA (Ranked No. 1 in the US).
Education & Training
Ph.D. in Clinical Medicine, Fudan University Shanghai Medical College (Supervisor: Prof. Liu Luming).
Awards & Honors
Received 4 provincial and ministerial level Medical Science and Technology Progress Awards, including the Second Prize of Shanghai Science and Technology Progress Award, the Second Prize of Science and Technology Progress Award of the Ministry of Education, and the First Prize of the Association of Integrative Medicine.
Academic & Professional Memberships
Vice Chairman, Tumor Ablation Treatment Committee, Shanghai Anti-Cancer Association.
Member, 2nd Pancreatic Disease Committee, Shanghai Association of Integrative Medicine.
Member, Tumor Interventional Committee, China Research Hospital Association.
Member, Traditional Medicine Committee, Shanghai Anti-Cancer Association.
Research & Publications
Presided over 4 national-level projects, including the National Natural Science Foundation and the National Key R&D Program of the Ministry of Science and Technology.
Presided over multiple provincial and ministerial research projects, including the Shanghai Municipal Science and Technology Commission Natural Science Foundation, Shanghai Municipal Health Commission projects, and Ministry of Civil Affairs projects.
Participated as a key member in over 20 research projects, including the "International Center of TCM for Cancer" (R21, U19, R01) funded by the US National Cancer Institute (NCI) and Ministry of Science and Technology international cooperation projects.
Published over 40 papers in domestic and international academic journals as first or corresponding author, including over 10 SCI-indexed papers.
Co-edited 5 medical books.
Selected Peer-Reviewed Publications
Huang C, Cheng CS, Shen Y, et al. (2024). Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy. BMC Cancer. 24(1):941. PMID: 39095759
Yan X, Ning ZY, Wang P, et al. (2021). Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study. Expert Rev Gastroenterol Hepatol. 15(9):1047-1056. PMID: 33356652
Shen Y, Liu L, Chiang JS, et al. (2015). Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea. Cancer. 121(1):84-92. PMID: 25204437
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Shen’s expertise relevant to my specific diagnosis?
Dr. Shen’s clinical focus includes pancreatic cancer, primary and metastatic liver cancer, gallbladder cancer, cholangiocarcinoma, gastrointestinal tumors, and minimally invasive approaches such as radiofrequency ablation, arterial infusion chemotherapy and HIFU. For a case-specific opinion, MedBridgeNZ can coordinate preparation, translation and transfer of your medical records for a remote specialist review by Dr. Shen before you decide whether to travel to Shanghai.
How can an international patient request an appointment with Dr. Shen?
MedBridgeNZ coordinates appointment requests and communication with Fudan University Shanghai Cancer Center for international patients seeking care with Dr. Shen. We can also assist with medical-record translation coordination, medical invitation or visa-document support, accommodation and travel planning, and non-clinical bilingual administrative support during hospital visits in Shanghai.
Can Dr. Shen review my medical records before I travel to China?
Yes. MedBridgeNZ can coordinate a remote specialist review with Dr. Shen before international travel. After your records are prepared, translated where needed, and transferred with your authorization, Dr. Shen reviews the submitted materials and provides an independent specialist opinion and recommendations, including responses to the questions submitted for review. MedBridgeNZ handles the administrative coordination and communication around this process.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist care in China. We coordinate appointment requests, medical-record preparation and translation, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment; clinical opinions and recommendations are provided by the relevant independent specialist or hospital. Hospital, specialist and other third-party costs are separate unless expressly stated in writing.